Association of
International
Pharmaceutical
Manufacturers
Ассоциация
международных
фармацевтических
производителей
+7 (495) 933-7040
SECRETARIAT@AIPM.ORG
RU EN



Vaccination against COVID-19

The COVID-19 pandemic is a challenge to public health around the world. The pharmaceutical industry together with regulatory authorities and professional community are making unpresidential efforts to find a solution that would protect humanity from this threat. AIPM member companies, who have research and development expertise both in the areas of nature of viruses and the spread of infectious diseases, as well as in the development of vaccines, drugs, and disease diagnostics systems, are convinced of the importance of universal vaccination against COVID-19 to overcome the health crisis.

Immunization has always been the key and most effective method of protecting human health and combating infectious diseases. It saves millions of lives every year by protecting against life-threatening infections, and with the emergence of the COVID-19 pandemic, their importance has increased significantly. Vaccines reduce the risk of infection and are critical for preventing and suppressing infectious disease outbreaks. Vaccination against coronavirus infection is humanity’s hope of moving out of the shadow of the COVID-19 pandemic and returning to normal life. To do this, vaccines need to be available to the widest possible range of people around the world; the responsible approach of each person to the issue of vaccination is also vital.

None is safe until everyone is safe.

Useful information:

Up